tiprankstipranks
Boundless Bio Inc. (BOLD)
NASDAQ:BOLD
US Market

Boundless Bio Inc. (BOLD) Income Statement

Compare
29 Followers

Boundless Bio Inc. Income Statement

Last quarter (Q3 2024), Boundless Bio Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Boundless Bio Inc.'s net income was $-16.51M. See Boundless Bio Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 18
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -957.00K$ -942.00K$ -682.00K$ 0.00
Operating Expenses
$ 54.80M$ 46.47M$ 25.30M$ 134.37M
Depreciation and Amortization
$ 957.00K$ 942.00K$ 682.00K$ 7.46M
EBITDA
$ -48.48M$ -45.53M$ -24.62M$ -121.36M
Operating Income
$ -54.80M$ -46.47M$ -25.30M$ -134.37M
Other Income/Expenses
$ 5.36M$ 568.00K$ 91.00K$ 5.55M
Pretax Income
$ -49.43M$ -45.90M$ -25.21M$ -128.82M
Net Income
$ -49.43M$ -45.90M$ -25.21M$ -128.82M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -2.22$ -2.06$ -1.13$ -2.93
Diluted EPS
$ -2.22$ -2.06$ -1.13$ -2.93
Weighted Average Shares Outstanding
22.24M 22.24M 22.24M 44.03M
Weighted Average Shares Outstanding (Diluted)
22.24M 22.24M 22.24M 44.03M
Currency in USD

Boundless Bio Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis